# A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects

> **NCT06081465** · PHASE1 · RECRUITING · sponsor: **Zhejiang Vimgreen Pharmaceuticals, Ltd.** · enrollment: 86 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** VG290131

## Key facts

- **NCT ID:** NCT06081465
- **Lead sponsor:** Zhejiang Vimgreen Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-20
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2024-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06081465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06081465, "A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06081465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*